Association of KIR3DL1/S1 and HLA-Bw4 with CD4 T cell counts in HIV-infected Mexican mestizos

被引:8
|
作者
Hernandez-Ramirez, Daniel [1 ]
Esparza-Perez, Mario A. [2 ]
Ramirez-Garcialuna, Jose L. [1 ]
Rafael Arguello, J. [3 ]
Mandeville, Peter B. [1 ]
Noyola, Daniel E. [4 ]
Garcia-Sepulveda, Christian A. [1 ]
机构
[1] Univ Autonoma San Luis Potosi, Fac Med, Lab Genom Viral & Humana, San Luis Potosi 78210, Slp, Mexico
[2] Serv Salud Estado San Luis Potosi, CAPASITS, San Luis Potosi 78210, Slp, Mexico
[3] Univ Autnoma Coahuila, Fac Med, Torreon 27000, Coah, Mexico
[4] Univ Autonoma San Luis Potosi, Fac Med, Dept Microbiol, Lab Virol, San Luis Potosi 78210, Slp, Mexico
关键词
CD4 lymphocyte count; HIV infections; Acquired immunodeficiency syndrome; Killer-cell immunoglobulin-like receptor; Immunogenetics; NATURAL-KILLER-CELLS; IMMUNOGLOBULIN-LIKE RECEPTORS; HLA CLASS-I; MOLONEY LEUKEMIA-CELLS; CUTTING EDGE; CYTOTOXIC-CELLS; SELF-TOLERANCE; UNITED-STATES; KIR; KIR3DS1;
D O I
10.1007/s00251-015-0848-z
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Certain genotypic combinations of killer-cell immunoglobulin-like receptors (KIR) and human leukocyte antigens (HLA) have been associated with favourable outcomes after exposure to human immunodeficiency virus in Caucasoid and African populations. Human immunodeficiency virus (HIV) infection is characterized by a rapid exhaustion of CD4 cells, which results in impaired cellular immunity. During this early phase of infection, it is thought that the natural killer (NK) cells represent the main effector arm of the host immune response to HIV. This study investigates whether KIR and HLA factors are associated to CD4 T cell numbers after HIV infection in Mexican mestizos as assessed at the time of initial medical evaluation and subsequent clinical follow-up. KIR and HLA-B gene carrier frequency differences were compared between groups of patients stratified by CD4 T cell numbers as assessed during their first medical evaluation (a point in time at which all patients were anti-retroviral therapy na < ve). In addition, the influence that these genetic factors have on averaged historical CD4 cell counts in patients subjected to follow-up (mostly therapy-experienced) was also evaluated. Our results suggest a protective role for the HLA-Bw4 and KIR3D + Bw4 combination in both therapy-na < ve and therapy-experienced patients. This report furthers our understanding on the way that immune genes modulate HIV disease progression in less-studied human populations such as the Mexican mestizos with a special focus on CD4 T cell number and behaviour.
引用
收藏
页码:413 / 424
页数:12
相关论文
共 50 条
  • [11] Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab
    Erbe, Amy K.
    Wang, Wei
    Carmichael, Lakeesha
    Hoefges, Anna
    Grzywacz, Bartosz
    Reville, Patrick K.
    Ranheim, Erik A.
    Hank, Jacquelyn A.
    Kim, KyungMann
    Seo, Songwon
    Mendonca, Eneida A.
    Song, Yiqiang
    Kenkre, Vaishalee P.
    Hong, Fangxin
    Gascoyne, Randy D.
    Paietta, Elisabeth
    Horning, Sandra J.
    Miller, Jeffrey S.
    Kahl, Brad
    Sondel, Paul M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [12] Allele diversity of the killer cell immunoglobulin-like receptors KIR3DL1/S1 and the combination with their HLA ligands in Mexican Mestizos from Mexico City
    Gonzalez-Quezada, B. A.
    Sanchez-Fernandez, M. G. J.
    Munguia-Saldana, A. J.
    Valencia-Macedo, M. E.
    Flores-Aguilar, H.
    Bonilla-Galan, E.
    Rodriguez-Gomez, A.
    Diaz-Rivera, A.
    Gorodezky, C.
    HUMAN IMMUNOLOGY, 2018, 79 (12) : 834 - 838
  • [13] EFFECTS OF KIR 3DL1 AND HLA-BW4 MISCLASSIFICATION ON DONOR SELECTION FOR NATURAL KILLER CELL THERAPY
    Turner, E. Victoria
    Leung, Wing H.
    HUMAN IMMUNOLOGY, 2014, 75 : 47 - 47
  • [14] HIV Protective KIR3DL1/S1-HLA-B Genotypes Influence NK Cell-Mediated Inhibition of HIV Replication in Autologous CD4 Targets
    Song, Rujun
    Lisovsky, Irene
    Lebouche, Bertrand
    Routy, Jean-Pierre
    Bruneau, Julie
    Bernard, Nicole F.
    PLOS PATHOGENS, 2014, 10 (01)
  • [15] The killer immunoglobulin-like receptor KIR3DL1 in combination with HLA-Bw4 is protective against multiple sclerosis in African Americans
    Hollenbach, J. A.
    Pando, M. J.
    Caillier, S. J.
    Gourraud, P-A
    Oksenberg, J. R.
    GENES AND IMMUNITY, 2016, 17 (03) : 199 - 202
  • [16] Both the nature of KIR3DL1 alleles and the KIR3DL1/S1 allele combination affect the KIR3DL1 NK-cell repertoire in the French population
    Gagne, Katia
    Willem, Catherine
    Legrand, Nolwenn
    Djaoud, Zakia
    David, Gaelle
    Rettman, Pauline
    Bressollette-Bodin, Celine
    Senitzer, David
    Esbelin, Julie
    Cesbron-Gautier, Anne
    Schneider, Thierry
    Retiere, Christelle
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2013, 43 (04) : 1085 - 1098
  • [17] The killer immunoglobulin-like receptor KIR3DL1 in combination with HLA-Bw4 is protective against multiple sclerosis in African Americans
    J A Hollenbach
    M J Pando
    S J Caillier
    P-A Gourraud
    J R Oksenberg
    Genes & Immunity, 2016, 17 : 199 - 202
  • [18] Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1
    Alicata, Claudia
    Pende, Daniela
    Meazza, Raffaella
    Canevali, Paolo
    Loiacono, Fabrizio
    Bertaina, Alice
    Locatelli, Franco
    Nemat-Gorgani, Neda
    Guethlein, Lisbeth A.
    Parham, Peter
    Moretta, Lorenzo
    Moretta, Alessandro
    Bottino, Cristina
    Norman, Paul J.
    Falco, Michela
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 (06) : 1511 - 1517
  • [19] KIR3DS1/HLA-Bw4 distribution in the Tunisian population
    Louati, Sirine
    Charfi, Aida
    Kamoun, Arwa
    Mahfoudh, Nadia
    Makni, Hafedh
    HLA, 2023, 101 (04) : 422 - 422
  • [20] Under Representation of the Inhibitory KIR3DL1 Molecule and the KIR3DL1+/BW4+ Complex in HIV Exposed Seronegative Individuals
    Guerini, Franca Rosa
    Lo Caputo, Sergio
    Gori, Andrea
    Bandera, Alessandra
    Mazzotta, Francesco
    Uglietti, Alessia
    Zanzottera, Milena
    Maserati, Renato
    Clerici, Mario
    JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (09): : 1235 - 1239